GRAL
GRAIL Inc.
$54.42
+$3.77(+7.44%)
48
Overall
60
Value
30
Tech
55
Quality
Market Cap
$2.97B
Volume
590.72K
52W Range
$29.95 - $118.84
Target Price
$67.71
Company Overview
| Mkt Cap | $2.97B | Price | $54.42 |
| Volume | 590.72K | Change | +7.44% |
| P/E Ratio | -1.5 | Open | $50.99 |
| Revenue | $125.6M | Prev Close | $50.65 |
| Net Income | $-2.0B | 52W Range | $29.95 - $118.84 |
| Div Yield | N/A | Target | $67.71 |
| Overall | 48 | Value | 60 |
| Quality | 55 | Technical | 30 |
No chart data available
About GRAIL Inc.
GRAIL, Inc., a commercial-stage healthcare company, focuses on developing technologies for early cancer detection in the United States and internationally. It provides Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company offers development services including support for ongoing clinical studies, pilot testing, research, and therapy development. It also develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRAL | $54.42 | +7.4% | 590.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |